Eudaimonia Partners’s VivoSim Labs VIVS Stock Holding History

Eudaimonia Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	-$1K	–	1419
2021 Q1	$1K	Buy	+7	New	+$1.09K	﹤0.01%	1589

Other funds holding VIVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eudaimonia Partners's VIVS Position: Q2 2021 in Review

Eudaimonia Partners sold out of VivoSim Labs (VIVS) in Q2 2021, closing a stake of 7 shares — an estimated $1K sold.

Eudaimonia Partners first reported a position in VIVS in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 50 funds tracked by Wall St. Rank hold VIVS as of Q2 2021.

Eudaimonia Partners reported no remaining VivoSim Labs position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 7 VivoSim Labs shares in Q2 2021, an estimated $1K.
Eudaimonia Partners first reported a position in VivoSim Labs in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's VivoSim Labs position peaked at $1K in Q1 2021.
50 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.